Fagron N.V.
A global pharmaceutical compounding company focused on personalized medicine.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Manufacturing
Description
Fagron N.V. is a global company active in pharmaceutical compounding, focusing on the delivery of personalized medicine. The company optimizes and innovates compounding to widen the therapeutic options for prescribers worldwide. Fagron develops, markets, and distributes pharmaceutical raw materials, equipment, and specially formulated vehicles and bases, such as the Pentravan® transdermal base and the SyrSpend® range of oral suspending vehicles. Its primary customers are hospitals, pharmacies, and clinics. The company also operates in the field of genomics to further support personalized healthcare solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-04-09 21:00 |
ENG Proxy AGM and EGM 10 May 2021.pdf
|
English | 992.6 KB | ||
| 2021-04-09 21:00 |
Remuneratiebeleid 2021 - NL.pdf
|
Dutch | 2.2 MB | ||
| 2021-04-09 21:00 |
ENG Report 7-199 BoD authorized capital - website.pdf
|
English | 751.6 KB | ||
| 2021-04-09 21:00 |
NE Ontwerp Statuten Fagron NV.pdf
|
Dutch | 203.7 KB | ||
| 2021-04-09 21:00 |
ENG Background information for shareholders AGM and EGM 10 May 2021.pdf
|
English | 691.3 KB | ||
| 2021-04-09 21:00 |
NE Achtergrondinformatie voor aandeelhouders AVA en BAV 10 mei 2021.pdf
|
Dutch | 780.7 KB | ||
| 2021-04-09 21:00 |
Oproeping ENG DEF.pdf
|
English | 88.1 KB | ||
| 2021-04-09 21:00 |
Fagron NV Statutaire jaarrekening Finaal.pdf
|
Dutch | 2.2 MB | ||
| 2021-04-09 21:00 |
FAGRON JV2020 NL-IA.pdf
|
Dutch | 7.9 MB | ||
| 2021-02-11 08:26 |
Fagron delivers solid results in exceptional 2020
|
English | 58.7 KB | ||
| 2021-02-11 07:00 |
Fagron 2020 Results DEF ENG.pdf
|
English | 473.6 KB | ||
| 2021-02-11 07:00 |
Fagron 2020 Results DEF NED.pdf
|
Dutch | 486.6 KB | ||
| 2021-01-29 08:25 |
Disclosure of received notification of BNP Paribas Asset Management SA
|
English | 104.2 KB | ||
| 2021-01-29 08:25 |
Disclosure of received notification of BNP Paribas Asset Management SA
|
Dutch | 97.1 KB | ||
| 2021-01-29 07:00 |
tr-1be-fr_FAGRON_28JAN21.pdf
|
French | 321.3 KB |
Automate Your Workflow. Get a real-time feed of all Fagron N.V. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Fagron N.V.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Fagron N.V. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
